April 29, 2010 – Anti-Infective Drugs Advisory Committee
NDA – artesunate rectal suppositories (WHO)
Agenda: On April 29, 2010, the committee will discuss the efficacy and safety of new drug application (NDA) 21-242, artesunate rectal suppositories, submitted by the World Health Organization, for the proposed use as a single dose for the initial treatment of patients with acute malaria who cannot take medication by mouth and for whom injectable treatment is not available.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment